Associate Director, Bioinformatics
AstraZeneca
Dr. Gopalakrishnan is an Associate Director, Bioinformatics in the Early Vaccines and Immune Therapies group at AstraZeneca. He has a PhD in epidemiology, during which time he led a pivotal study that uncovered differential microbiome signatures related to cancer therapy. Currently, his research is focused on analyzing genomic and metagenomic next generation sequencing data for identification of therapeutic targets, and to better understand associations with clinical outcomes in infectious diseases.